May 24, 2018
Novartis’s Zessly approved in Europe
Novartis’s Sandoz has secured European Commission’s approval for biosimilar Zessly, the company said Thursday.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Zessly
Pharmaceuticals, Biotechnology and Life Sciences
Novartis’s Sandoz has secured European Commission’s approval for biosimilar Zessly, the company said Thursday.